MJBizCon 2023 Interviews: Richard Drennen: BDO
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
NEWS: Psilocybin Could Help Prevent Debilitating Nerve Damage Caused by Chemotherapy
AUSTIN, Texas - New research from MD Anderson suggests psilocybin may protect peripheral nerves before chemotherapy damage occurs, with a Phase II human trial expected to begin later this year. A new study from The ...
Elixinol Offloads Its US Hemp Business to Ananda Health
SYDNEY – Australian Elixinol Wellness Limited has entered into a binding asset purchase agreement with Ananda Health to sell its wholly-owned subsidiary, Elixinol LLC, effectively exiting the United States hemp market. Under the transaction terms, ...
ARPA-H Launches ASCENT-IBO Initiative for Ibogaine Clinical Research
WASHINGTON – The Advanced Research Projects Agency for Health (ARPA-H) has launched a federal research opportunity aimed at accelerating clinical evaluations of ibogaine for Opioid Use Disorder (OUD). Titled ASCENT-IBO, short for Accelerating Safe Clinical ...
